A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations. US pharmaceutical major Pfizer has......
An end to Sun Pharma founder Dilip Shanghvi's woes are not in sight. In 2015 Dilip Shanghvi dislodged Reliance's Mukesh Ambani as India’s wealthiest person. With a net worth of $21.7......
Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator. Seoul-based biotech company Mezzion Pharma has filed a suit against Dr Reddy’s......
The US Food and Drug Administration (FDA) says it does not follow an India agenda. Howard R Sklamberg (below left), deputy commissioner, global regulatory operations and policy, FDA, tells Digbijay......
The Ranbaxy brand might be gradually phased out in the near future in the wake of this year’s largest merger in the Asian pharma sector. After Monday’s conditional nod from the......